Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Shareholders' Equity (Tables)

v3.24.2.u1
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2024
Shareholders Equity [Abstract]  
Schedule of Fair value of Company’s Share Options Granted The fair value of the Company’s share options granted was estimated using the binomial option pricing model using the following range assumptions:
Description   May 7,
2024
 
       
Risk-free interest rate     4.64 %
Expected volatility     83.40 %
Dividend yield     0 %
Contractual life (in years)     10  
Early Exercise Multiple (Suboptimal Factor)     2.5  
Schedule of Weighted Average Exercise Prices Share Options The following table lists the number of share options and their weighted average exercise prices in option plans of employees, directors and consultants for the six months period ended June 30, 2024 and related information:
    Number of options     Weighted
average
exercise
price
    Weighted
average
remaining
contractual
terms (in
years)
    Aggregate
intrinsic
value
 
                         
Outstanding at December 31, 2023     82,477,000       0.04       8.40      
-
 
Grants     9,000,000       0.00       9.85      
-
 
Forfeited/expired     (5,412,500 )    
-
      -      
-
 
                                 
Outstanding at June 30, 2024     86,064,500       0.04       5.6       0.04  
                                 
Vested and expected to vest at June 30, 2024     86,064,500       0.04       5.6       0.04  
                                 
Exercisable at June 30, 2024     33,998,875       0.08       5.4      
-
 
Schedule of Expenses Recognized Financial Statements Share based expenses recognized in the financial statements:
    Six months ended
June 30
 
    2024     2023  
             
Research and development   $ 34     $ 50  
General and administrative (*)     159       45  
                 
    $ 193     $ 95  
(*) Including expenses for shares issued for services at the amount of $112, refer to Note 4c above.

 

Schedule of Information Regarding Outstanding Warrants to Purchase Shares The following table summarizes information regarding outstanding warrants to purchase the Company’s ordinary shares as of June 30, 2024:
Issuance date   Number of
outstanding
Warrants
    Exercise
price per
warrant
 
             
January 2019     223,810     $ 0.65  
May 2019     47,250,000     $ 0.13  
January 2020     23,838,038     $ 0.12  
February 2020     11,250,000     $ 0.05  
June 2020     61,390,260     $ 0.08  
July 2020     29,419,890     $ 0.08  
August 2021     10,500,000     $ 0.07  
December 2021     10,500,000     $ 0.07  
January 2023     409,091,100     $ 0.01  
January 2023     28,636,500     $ 0.02  
November 2023     1,219,418,700     $ 0.00  
                 
      1,851,518,298